METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR
Purification of .alpha.-1 proteinase inhibitor (.alpha.-1 PI) from aqueous solutions, such as human plasma, is accomplished by precipitation of contaminating proteins from the aqueous solution, followed by dilution of th e solution to adjust its conductivity, and passing of the solution through an a...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LEBING, WYTOLD WOOD, WOODY D OWNBY, DAVID W TRUKAWINSKI, SUSAN CHAVEZ, MARK D |
| description | Purification of .alpha.-1 proteinase inhibitor (.alpha.-1 PI) from aqueous solutions, such as human plasma, is accomplished by precipitation of contaminating proteins from the aqueous solution, followed by dilution of th e solution to adjust its conductivity, and passing of the solution through an anion exchange resin. The conductivity of the solution is adjusted so that t he .alpha.-1 PI binds to the anion exchange resin, while other contaminating proteins and solvent pass though the resin. Further purification may be accomplished by cation chromatography, which takes advantage of the fact tha t .alpha.-1 PI does not bind to the cation column under certain conditions. So me embodiments of the invention also include virus removal and/or inactivation by methods such as nanofiltration and such as contact with a non-ionic detergen t. The methods of the present invention result in greater yield, purity, and pathogenic clearance of plasma fractions than known methods. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2432641A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2432641A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2432641A13</originalsourceid><addsrcrecordid>eNrjZDDwdQ3x8HdR8HdTCAhyDXAM8vRzV3D0CfBw1DUEiviHuHr6OQa7Knj6eXg6eYb4B_EwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknhnRyMTYyMzE0NHQ2MilAAAyrEljQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR</title><source>esp@cenet</source><creator>LEBING, WYTOLD ; WOOD, WOODY D ; OWNBY, DAVID W ; TRUKAWINSKI, SUSAN ; CHAVEZ, MARK D</creator><creatorcontrib>LEBING, WYTOLD ; WOOD, WOODY D ; OWNBY, DAVID W ; TRUKAWINSKI, SUSAN ; CHAVEZ, MARK D</creatorcontrib><description>Purification of .alpha.-1 proteinase inhibitor (.alpha.-1 PI) from aqueous solutions, such as human plasma, is accomplished by precipitation of contaminating proteins from the aqueous solution, followed by dilution of th e solution to adjust its conductivity, and passing of the solution through an anion exchange resin. The conductivity of the solution is adjusted so that t he .alpha.-1 PI binds to the anion exchange resin, while other contaminating proteins and solvent pass though the resin. Further purification may be accomplished by cation chromatography, which takes advantage of the fact tha t .alpha.-1 PI does not bind to the cation column under certain conditions. So me embodiments of the invention also include virus removal and/or inactivation by methods such as nanofiltration and such as contact with a non-ionic detergen t. The methods of the present invention result in greater yield, purity, and pathogenic clearance of plasma fractions than known methods.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020620&DB=EPODOC&CC=CA&NR=2432641A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020620&DB=EPODOC&CC=CA&NR=2432641A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEBING, WYTOLD</creatorcontrib><creatorcontrib>WOOD, WOODY D</creatorcontrib><creatorcontrib>OWNBY, DAVID W</creatorcontrib><creatorcontrib>TRUKAWINSKI, SUSAN</creatorcontrib><creatorcontrib>CHAVEZ, MARK D</creatorcontrib><title>METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR</title><description>Purification of .alpha.-1 proteinase inhibitor (.alpha.-1 PI) from aqueous solutions, such as human plasma, is accomplished by precipitation of contaminating proteins from the aqueous solution, followed by dilution of th e solution to adjust its conductivity, and passing of the solution through an anion exchange resin. The conductivity of the solution is adjusted so that t he .alpha.-1 PI binds to the anion exchange resin, while other contaminating proteins and solvent pass though the resin. Further purification may be accomplished by cation chromatography, which takes advantage of the fact tha t .alpha.-1 PI does not bind to the cation column under certain conditions. So me embodiments of the invention also include virus removal and/or inactivation by methods such as nanofiltration and such as contact with a non-ionic detergen t. The methods of the present invention result in greater yield, purity, and pathogenic clearance of plasma fractions than known methods.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDwdQ3x8HdR8HdTCAhyDXAM8vRzV3D0CfBw1DUEiviHuHr6OQa7Knj6eXg6eYb4B_EwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknhnRyMTYyMzE0NHQ2MilAAAyrEljQ</recordid><startdate>20020620</startdate><enddate>20020620</enddate><creator>LEBING, WYTOLD</creator><creator>WOOD, WOODY D</creator><creator>OWNBY, DAVID W</creator><creator>TRUKAWINSKI, SUSAN</creator><creator>CHAVEZ, MARK D</creator><scope>EVB</scope></search><sort><creationdate>20020620</creationdate><title>METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR</title><author>LEBING, WYTOLD ; WOOD, WOODY D ; OWNBY, DAVID W ; TRUKAWINSKI, SUSAN ; CHAVEZ, MARK D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2432641A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>LEBING, WYTOLD</creatorcontrib><creatorcontrib>WOOD, WOODY D</creatorcontrib><creatorcontrib>OWNBY, DAVID W</creatorcontrib><creatorcontrib>TRUKAWINSKI, SUSAN</creatorcontrib><creatorcontrib>CHAVEZ, MARK D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEBING, WYTOLD</au><au>WOOD, WOODY D</au><au>OWNBY, DAVID W</au><au>TRUKAWINSKI, SUSAN</au><au>CHAVEZ, MARK D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR</title><date>2002-06-20</date><risdate>2002</risdate><abstract>Purification of .alpha.-1 proteinase inhibitor (.alpha.-1 PI) from aqueous solutions, such as human plasma, is accomplished by precipitation of contaminating proteins from the aqueous solution, followed by dilution of th e solution to adjust its conductivity, and passing of the solution through an anion exchange resin. The conductivity of the solution is adjusted so that t he .alpha.-1 PI binds to the anion exchange resin, while other contaminating proteins and solvent pass though the resin. Further purification may be accomplished by cation chromatography, which takes advantage of the fact tha t .alpha.-1 PI does not bind to the cation column under certain conditions. So me embodiments of the invention also include virus removal and/or inactivation by methods such as nanofiltration and such as contact with a non-ionic detergen t. The methods of the present invention result in greater yield, purity, and pathogenic clearance of plasma fractions than known methods.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2432641A1 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T20%3A30%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEBING,%20WYTOLD&rft.date=2002-06-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2432641A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |